Keyphrases
Confidence Interval
100%
Hazard Ratio
100%
Pemphigus
100%
Infection Risk
100%
Mycophenolate Mofetil
100%
Rituximab
100%
International Cohort
100%
Cytomegalovirus Infection
25%
COVID-19 Risk
25%
Osteomyelitis
25%
COVID-19
12%
World Population
12%
First Year
12%
Population-based Cohort Study
12%
Cytomegalovirus
12%
Propensity Score Matching
12%
COVID-19 Infection
12%
Pneumonia
12%
Tuberculosis
12%
Antiretroviral Therapy
12%
Infectious Complications
12%
Viral Disease
12%
Drug Use Initiation
12%
Pneumococcal Vaccine
12%
Herpes Simplex Virus
12%
Pneumocystis Jirovecii
12%
Parasitic Diseases
12%
Parasitic Infection
12%
Hepatitis B Virus Reactivation
12%
Corticosteroid-sparing
12%
Progressive multifocal Leukoencephalopathy
12%
Pneumonia Disease
12%
Medicine and Dentistry
Infection
100%
Cohort Analysis
100%
Hazard Ratio
100%
Pemphigus
100%
Rituximab
100%
Azathioprine
100%
Mycophenolate Mofetil
100%
COVID-19
37%
Osteomyelitis
25%
Cytomegalovirus Infection
25%
Cytomegalovirus
12%
Hepatitis B Virus
12%
Propensity Score Matching
12%
Antiviral Therapy
12%
Virus Infection
12%
Pneumococcus Vaccine
12%
Herpes Simplex Virus
12%
Pneumocystis Pneumonia
12%
Infectious Complication
12%
Parasitic Disease
12%
Progressive Multifocal Leukoencephalopathy
12%
Virus Reactivation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Cohort Study
100%
Azathioprine
100%
Pemphigus
100%
Rituximab
100%
Mycophenolate Mofetil
100%
Cytomegalovirus Infection
25%
Osteomyelitis
25%
Hepatitis B Virus
12%
Pneumococcus Vaccine
12%
Virus Infection
12%
Antiviral Therapy
12%
Cytomegalovirus
12%
Infectious Complication
12%
Pneumocystis Pneumonia
12%
Herpes Simplex Virus
12%
Diseases
12%
Progressive Multifocal Leukoencephalopathy
12%
Immunology and Microbiology
Rituximab
100%
Pemphigus
100%
Azathioprine
100%
Mycophenolate Mofetil
100%
COVID-19
37%
Cytomegalovirus Infection
25%
Infectious Disease
12%
Viral Disease
12%
Pneumococcal Vaccine
12%
Hepatitis B Virus
12%
Cytomegalovirus
12%
Pneumocystis jiroveci
12%
Virus Reactivation
12%
Herpes Simplex Virus
12%